News

We are pleased to inform you that our website has been fully redesigned. The redesign and improvement are aimed at more user-friendly design and providing useful information for customers this time. We added...

Kishi Kasei Co., Ltd. (President: Daisuke Maezawa) and Spera Pharma, Inc. (President: Toshio Yoshioka) have agreed to a business collaboration combining Kishi Kasei’s contract manufacturing of Biomaterials and...

At the 4th International Symposium for Medicinal Sciences held on March 27, at Kanazawa Art Hall/Kanazawa Motenashi Dome during the 138th Annual Meeting of The Pharmaceutical Society of Japan (March 25 - 28), ...

At The 12th Process Chemistry Lounge, held at the Yugawara Traning Center of Wako Pure Chemical Industries, Ltd., on December 1 - 2, 2017, Kazuki Azuma of Chemical R&D Division gave a lecture on "Development o...

At the 2017 Winter Symposium of the Japanese Society of Process Chemistry held in Nagasaki city on December 8, 2017, the JSPC Award Ceremony was held for the awardees selected at the 2017 Summer Symposium. Say...

An article on API process research in the Chemical R&D Division of the company has been published and is described by one of the authors, Dr. Ikemoto. http://pubs.acs.org/doi/10.1021/acs.oprd.7b00313 Title: ...

Spera Pharma exhibited a company's booth at The 38th Annual Scientific Meeting of the Japanese Society of Clinical Pharmacology and Therapeutics, which was held for three days from December 7, 2017 at PACIFIC...

Spera Pharma made a debut exhibit at CPhI worldwide 2017, which was held for three days from October 24, 2017 in Frankfurt, Germany. Details of the Spera Pharma business model and technologies were actively pr...

A researcher in the Chemical R&D Division of Spera Pharma, Osamu Yabe, gave a poster presentation (2P-076) at The 35th Medicinal Chemistry Symposium, which was held on October 25∼27 in the Toyota Lecture Hall ...

Spera Pharma exhibited a company's booth at The 35th Medicinal Chemistry Symposium held at Nagoya University (October 25∼26). Many attendees from pharmaceutical companies, venture companies and academia visit...